Historically, plasminogen-system degrades stroma-derived fibrin in ovarian cancer (OvCa) ascites45 and high levels of plasminogen-system inhibitor PAI-1 in ascites prolong disease free survival in late stage 3 OvCa patients46,47. This evidence concerns the gene PLG and ovarian cancer.